Literature DB >> 28904196

Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Melissa R Ryerson1, Monique M Richards1, Marc Kvansakul2, Christine J Hawkins2, Joanna L Shisler3.   

Abstract

Apoptosis is an important antiviral host defense mechanism. Here we report the identification of a novel apoptosis inhibitor encoded by the vaccinia virus (VACV) M1L gene. M1L is absent in the attenuated modified vaccinia virus Ankara (MVA) strain of VACV, a strain that stimulates apoptosis in several types of immune cells. M1 expression increased the viability of MVA-infected THP-1 and Jurkat cells and reduced several biochemical hallmarks of apoptosis, such as PARP-1 and procaspase-3 cleavage. Furthermore, ectopic M1L expression decreased staurosporine-induced (intrinsic) apoptosis in HeLa cells. We then identified the molecular basis for M1 inhibitory function. M1 allowed mitochondrial depolarization but blocked procaspase-9 processing, suggesting that M1 targeted the apoptosome. In support of this model, we found that M1 promoted survival in Saccharomyces cerevisiae overexpressing human Apaf-1 and procaspase-9, critical components of the apoptosome, or overexpressing only conformationally active caspase-9. In mammalian cells, M1 coimmunoprecipitated with Apaf-1-procaspase-9 complexes. The current model is that M1 associates with and allows the formation of the apoptosome but prevents apoptotic functions of the apoptosome. The M1 protein features 14 predicted ankyrin (ANK) repeat domains, and M1 is the first ANK-containing protein reported to use this inhibitory strategy. Since ANK-containing proteins are encoded by many large DNA viruses and found in all domains of life, studies of M1 may lead to a better understanding of the roles of ANK proteins in virus-host interactions.IMPORTANCE Apoptosis selectively eliminates dangerous cells such as virus-infected cells. Poxviruses express apoptosis antagonists to neutralize this antiviral host defense. The vaccinia virus (VACV) M1 ankyrin (ANK) protein, a protein with no previously ascribed function, inhibits apoptosis. M1 interacts with the apoptosome and prevents procaspase-9 processing as well as downstream procaspase-3 cleavage in several cell types and under multiple conditions. M1 is the first poxviral protein reported to associate with and prevent the function of the apoptosome, giving a more detailed picture of the threats VACV encounters during infection. Dysregulation of apoptosis is associated with several human diseases. One potential treatment of apoptosis-related diseases is through the use of designed ANK repeat proteins (DARPins), similar to M1, as caspase inhibitors. Thus, the study of the novel antiapoptosis effects of M1 via apoptosome association will be helpful for understanding how to control apoptosis using either natural or synthetic molecules.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Apaf-1; M1L; ankyrin repeat; apoptosis; apoptosome; caspase-9; poxvirus; vaccinia virus

Mesh:

Substances:

Year:  2017        PMID: 28904196      PMCID: PMC5686757          DOI: 10.1128/JVI.01385-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  102 in total

1.  Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L.

Authors:  Maria Angel García; Susana Guerra; Jesús Gil; Victoria Jimenez; Mariano Esteban
Journal:  Oncogene       Date:  2002-12-05       Impact factor: 9.867

2.  Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis.

Authors:  Takashi Sakai; Li Liu; Xichuan Teng; Rika Mukai-Sakai; Hidenori Shimada; Ryuji Kaji; Tasuku Mitani; Mitsuru Matsumoto; Kazunori Toida; Kazunori Ishimura; Yuji Shishido; Tak W Mak; Kiyoshi Fukui
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

3.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

4.  Initial characterization of vaccinia virus B4 suggests a role in virus spread.

Authors:  Kristin Burles; Chad R Irwin; Robyn-Lee Burton; Jill Schriewer; David H Evans; R Mark Buller; Michele Barry
Journal:  Virology       Date:  2014-04-04       Impact factor: 3.616

Review 5.  Major apoptotic mechanisms and genes involved in apoptosis.

Authors:  Yağmur Kiraz; Aysun Adan; Melis Kartal Yandim; Yusuf Baran
Journal:  Tumour Biol       Date:  2016-04-09

6.  Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents.

Authors:  Liang Shen; Ci Chen; Xuan Wei; Xixian Li; Guangjin Luo; Jingwen Zhang; Jianping Bin; Xiaobo Huang; Shiping Cao; Guofeng Li; Yulin Liao
Journal:  Clin Sci (Lond)       Date:  2015-05-01       Impact factor: 6.124

7.  Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.

Authors:  L S Wyatt; M W Carroll; C P Czerny; M Merchlinsky; J R Sisler; B Moss
Journal:  Virology       Date:  1998-11-25       Impact factor: 3.616

8.  Regulation of apoptosis and anti-apoptosis signalling by Francisella tularensis.

Authors:  Marina Santic; Gordana Pavokovic; Snake Jones; Rexford Asare; Yousef Abu Kwaik
Journal:  Microbes Infect       Date:  2009-11-17       Impact factor: 2.700

9.  A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells.

Authors:  M A Brooks; A N Ali; P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Functional and biochemical characterization of the baculovirus caspase inhibitor MaviP35.

Authors:  I L Brand; M M Green; S Civciristov; D Pantaki-Eimany; C George; T R Gort; N Huang; R J Clem; C J Hawkins
Journal:  Cell Death Dis       Date:  2011-12-15       Impact factor: 8.469

View more
  7 in total

Review 1.  Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Zbigniew Wyżewski; Matylda Barbara Mielcarska; Karolina Paulina Gregorczyk-Zboroch; Anna Myszka
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.

Authors:  Amber B Rico; Alexandria C Linville; Annabel T Olson; Zhigang Wang; Matthew S Wiebe
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 3.  Contribution of yeast models to virus research.

Authors:  R Sahaya Glingston; Jyoti Yadav; Jitika Rajpoot; Neha Joshi; Shirisha Nagotu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.813

Review 4.  Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.

Authors:  Zong Sheng Guo; Binfeng Lu; Zongbi Guo; Esther Giehl; Mathilde Feist; Enyong Dai; Weilin Liu; Walter J Storkus; Yukai He; Zuqiang Liu; David L Bartlett
Journal:  J Immunother Cancer       Date:  2019-01-09       Impact factor: 13.751

Review 5.  Poxviral Strategies to Overcome Host Cell Apoptosis.

Authors:  Chathura D Suraweera; Mark G Hinds; Marc Kvansakul
Journal:  Pathogens       Date:  2020-12-23

Review 6.  Viral-mediated activation and inhibition of programmed cell death.

Authors:  Shayla Grace Verburg; Rebecca Margaret Lelievre; Michael James Westerveld; Jordon Marcus Inkol; Yi Lin Sun; Samuel Tekeste Workenhe
Journal:  PLoS Pathog       Date:  2022-08-11       Impact factor: 7.464

Review 7.  From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.

Authors:  Yaqiu Wang; Thirumala-Devi Kanneganti
Journal:  Comput Struct Biotechnol J       Date:  2021-08-03       Impact factor: 7.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.